@Article{, title={Estimation of immunological markers (IL1Alpha, IL-6 and CRP) in colorectal cancer in Iraqi patients Estimation of immunological markers (IL1Alpha, IL-6 and CRP) in colorectal cancer in Iraqi patients}, author={Hasan A. M. Aljezani and Israa H. Ali}, journal={Journal of Genetic and Environmental Resources Conservation مجلة صيانة المصادر الوراثية والبيئية}, volume={10}, number={2}, pages={178-183}, year={2022}, abstract={Cytokines are A type of protein that is made by certain immune and non-immune cells and has an effect on the immune system. Some cytokines stimulate the immune system and others slow it down. Interleukins (ILs) can be divided into several families with more than 40 subfamily members. They can interact with a variety of cells that alter the immune system and act on a wide range of cancers. In the past several years, ILs have attracted substantial attention because of their distinct roles in CRC that provide a new and promising strategy for CRC. In general, ILs facilitate CRC by promoting tumorigenesis, tumour growth, angiogenesis, and cancer cell invasion and metastasis and inhibit CRC via complex pathways. The Bioassay Technology Human Interleukin 6, Interleukin 1 alpha (E0090Hu) and C-reactive protein Kits was used. The quantitative determination of human interleukins concentrations and CRP were used in serum, plasma, cell culture supernatant, cell lysates and tissue homogenates .One hundred and twenty blood samples were collected from patients in gastrointestinal and hepatic hospital during the period from Feb 2019 to Feb 2020. Results revealed that the measuring the interleukin-alpha and intravenous blood levels of the subjects in our sample were different, but the difference with the other groups was very small, where the concentration rate was reported in the 699.84 ±51.39 colorectal cancer group and was similar to the other three groups, the average concentration of interleukin 6 in samples of patients with colorectal cancer was 48.81 + - 15.96 compared to the remaining groups, The analyses of the serum CRP concentration measurement were in patients with colorectal cancer, the concentration ratio was 31.45 ±7.94 relative to the performance of the other groups.

} }